Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP
Nutrients · 2024
DOI: 10.3390/nu16183071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Inmaculada Jurado-Robles und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biosceiences and Agrifood Sciences Program, University of Córdoba, 14004 Córdoba, Spain. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Sleep Apnea, Obstructive, Obesity, Comorbidity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity has increased cardiovascular morbidity and mortality. It is the leading risk factor for obstructive sleep apnoea (OSA). The relationship between obesity-OSA and vascular disease seems clear. There is no consensus on whether CPAP (continuous positive airway pressure) treatment prevents vascular events.
Objective
The aim of this study was to determine the effect of comorbidity and obesity on the risk of vascular events in patients with OSA treated with CPAP.
Method
This study was a prospective study of historical cohorts of adult patients with OSA and CPAP. The sample was 3017 patients. Descriptive, survival (Kaplan–Meier) and Cox regression analyses were performed, calculating crude and adjusted association relationships to explain the risk of vascular events.
Results
A total of 1726 patients were obese, 782 were diabetics, and 1800 were hypertensive. The mean adherence was 6.2 (±1.8 h/day), and the mean follow-up time was 2603 days (±953.3). In the COX regression analysis, the event-related variables were baseline age (HR: 1.025: 1.012–1.037; p < 0.001), pre-treatment vascular event (HR; 2.530: 1.959–3.266; p < 0.001), hypertension (HR; 1.871: 1.187–2.672; p = 0.005) and abbreviated Charlson comorbidity index (HR; 1.289: 1.100–1.510; p = 0.002).
Conclusions
The occurrence of vascular events in OSA patients on CPAP treatment is related to hypertension, having a vascular event before treatment, age at the start of CPAP use and abbreviated Charlson comorbidity index.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biosceiences and Agrifood Sciences Program, University of Córdoba, 14004 Córdoba, Spain.
- GA03 Pneumology Maimonides Institute of Biomedical Research (IMIBIC), 14004 Córdoba, Spain.
- Sleep Unit, Department of Respiratory Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.
- Nursing, Pharmacology and Physiotherapy Department, University of Córdoba, 14004 Córdoba, Spain.
- Lifestyles, Innovation and Health (GA-16), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain.
ORCID-Profile: Inmaculada Jurado-Robles, Bernabé Jurado-Gámez, Nuria Feu Collado, Rafael Molina-Luque, Guillermo Molina-Recio
Zitieren
APA
Jurado-Robles, I., Jurado-Gámez, B., Feu Collado, N., Molina-Luque, R., & Molina-Recio, G. (2024). Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP. Nutrients. https://doi.org/10.3390/nu16183071
Vancouver
Jurado-Robles I, Jurado-Gámez B, Feu Collado N, Molina-Luque R, Molina-Recio G. Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP. Nutrients. 2024. doi:10.3390/nu16183071
BibTeX
@article{JuradoRobles2024,
author = {Jurado-Robles, Inmaculada and Jurado-Gámez, Bernabé and Feu Collado, Nuria and Molina-Luque, Rafael and Molina-Recio, Guillermo},
title = {Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16183071}
}
EUVIMED